Short reportOpen Access

New York state health care provider participation in clinical trials: a brief report

Pathu Sriphanlop, Danielle M Crookes, Karen Demairo, Darryl Somayaji, Maureen Killackey, Anita McFarlane, Jean LePere, Lina Jandorf
Journal of Cancer Therapeutics & Research 2018 5 : 3 (25 November 2018)
Short reportOpen Access

Estimating tumour volume in a primary orthotopic mouse model of human pancreatic cancer using rapid acquisition magnetic resonance imaging

Neesha C Dhani, Ines  Lohse, Warren D Foltz, Ping-Jiang Cao, David W Hedley
Journal of Cancer Therapeutics & Research 2018 3 : 9 (13 July 2018)
Short reportOpen Access

Mutation analysis concerning possibility of cancer of unknown primary new treatment

Shoichiro Ohta, Yukiko Cho, Yasuharu Onishi, Kazuhiko Juni, Shinji Oshima, Osamu Hosoya, Nobuhiro Yasuno, Tatsuo Iijima, Hitoaki Saito, Masahiko Tanaka, Hiroshi Kojima
Journal of Cancer Therapeutics & Research 2013 2 : 2 (9 January 2013)
Short reportOpen Access

Antineoplastic activity of a methanolic extract from Kigelia pinnata DC stem bark

Georgi  Momekov, Denitsa  Momekova, Ivanka  Pencheva, Spiro  Konstantinov
Journal of Cancer Therapeutics & Research 2012 1 : 17 (19 July 2012)

Cancer Stem Cells

Journal of Cancer Therapetics & Research Open access Journal covers special section Cancer stem cells aims to publish research on identification, characterization and isolation of cancer stem cells in various cancer types, metastatic mechanisms, surface markers and their role in cancer initiation, progression and maintenance. The scope of the section includes reviews, hypothetical theories, clinical practices and novel techniques in regulating cancer stem cells.

Innovative Therapies

Journal of Cancer Therapetics & Research Open access Journal covers special section Innovative Therapies focuses on the treatment and prevention of cancer. This section inculdes cancer curing therapies and pharmaceutical applications with the study of anti-cancer drugs, therapeutic agents and Drug Development based on the signalling mechanisms and pharmacodynamics.

Carcinogenesis

Journal of Cancer Therapetics & Research Open access Journal contains special section Carcinogenesis covers the study of cells undergoing carcinogenesis with uncontrolled mutagenesis. It includes every aspect of biochemical mechanisms in relation to the cancer development. Also the focus is on medicinal research from diagnostic testing to monitoring of tumor progression through modulating agents and molecular epidemiology, examination of cells and tissues.

Organ Specific Cancers

Journal of Cancer Therapetics & Research Open access Journal covers special section Organ Specific Cancers, With its heterogenetic ability, Cancer has a diversified nature in relation to the organ specificity. This section encompasses study of cancer dvelopment in different organs and their transition among the organs. The primary focus is on heterogeneity, origin, metastasis, angiogenesis and organ specified mechanisms in cancer cells.

Radiation And Imaging

Journal of Cancer Therapetics & Research Open access Journal covers special section Radiation and Imaging section includes medical diagnostic procedures and treatment using radiation, chemotherapy and imaging technology. It focuses on the modified therapeutic strategies to control cancer and implementing preventional methods.

Epidemiology, Genetics And Genomics

Journal of Cancer Therapetics & Research Open access Journal covers special section Epidemiology Genetics and Genomics aim to attract papers in the field of epidemiology, genetics and genomics in cancer cells and cancer patients. Understanding the cancer genetics, gene expression and regulation in cancer cells, their heterogeneity will give new insights in diagnosis and treatment. The section intend to disseminate information and knowledge that may furnish novel applications such as personalized treatment with either DNA or protein kinase targeted drugs, combinations with modern radiotherapeutic approaches. The section also considers studies performing whole genome sequencing to recognize potential drug targets or limited for selected genes to identify patients responding to particular treatments more likely.